Pillstats
Rx only · Tablet, Film Coated · Oral

Montelukast Sodium

Brands: Montelukast · Singulair · Montelukast Sodium

16 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US22 NDCs
16 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)88249
US makers16 labelers
Packages62
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.420$0.840$1.26$1.68Dec 2025Mar 2026Jul 2026
$1.452
Latest avg · Jul 22, 2026
+2967%
Since Dec 17, 2025
16
Active US suppliers
42%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

471K942K1.4M1.9M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.3M
Rx · 2026 Q1
59.1M
Units dispensed
-16%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it16 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager16SUPPLYING
Proficient Rx LPunknown10SUPPLYING
Camber Pharmaceuticals, Inc.unknown5SUPPLYING
Aurobindo Pharma Limitedunknown5SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown4SUPPLYING
Preferred Pharmaceuticals Inc.unknown3SUPPLYING
Accord Healthcare Inc.unknown3SUPPLYING
NuCare Pharmaceuticals, Inc.unknown3SUPPLYING
Direct_Rxunknown2SUPPLYING
Organon LLCunknown2SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
Rising Pharma Holdings, Inc.unknown2SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown2SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

+ 1 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Feb 7, 2023
    RECALLRecall (Class II): Montelukast Sodium Tablets, USP, 10 mg* Rx Only, Packaged as: a) 30-count bottle NDC 16729-119-10 UPC 3 16729 11910 8; …

    CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada

  • Aug 20, 2018
    RECALLRecall (Class II): Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jad…

    Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets. — Recalling firm: Hetero Labs Limited Unit V — Nationwide in the USA

  • Aug 15, 2018
    RECALLRecall (Class I): Montelukast Sodium Tablets 10 mg, 30-count bottle, Rx Only, By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherl…

    Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg. — Recalling firm: Hetero Labs Limited Unit V — U.S.A. Nationwide

  • Jan 7, 2017
    RECALLRecall (Class III): Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway…

    Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle. — Recalling firm: Hetero USA Inc — US Nationwide